If it works, use Rehinged again.
Rehinged combines structured U.S. healthcare evidence, client-specific market models and specialized agents to test a portfolio company’s GTM assumptions — then turns the answer into scored markets and finished commercial work.
Before the round, the company explains why the market should exist.
After the round, the company has to prove who buys, where demand is concentrated and whether the motion repeats.
Sales hires, territories, quotas and marketing spend turn assumptions into fixed operating cost.
If the market thesis is wrong, the board usually learns after several quarters of execution against it.
Newly funded company choosing its first scalable market
Newly acquired company testing or rebuilding its commercial thesis
Company entering a second healthcare segment
CEO hiring the first VP Sales or field team
Board questioning whether weak pipeline is market, targeting, positioning or execution
New product or use case entering an existing market
Company entering U.S. healthcare for the first time
Company preparing the commercial thesis for the next raise
Mature team that already owns healthcare data but does not have the bandwidth to turn it into GTM work
Start with the portfolio company where the GTM question is most expensive.
Market research, model construction, enrichment and commercial synthesis once required analysts, strategists and long delivery cycles. Specialized agents can now perform much of that work — if they operate on real evidence, disciplined models and persistent client context.
Scored markets, buyer logic, reasons to call and finished GTM work — inside a persistent Rehinged Intelligence workspace.
The agents are not replacing the data. They are making the data economically usable.
EVERY PUBLISHED SCORE CARRIES ITS SOURCE AND DATE.
AcuityMD, Definitive Healthcare and Trella Health are established healthcare-data and workflow platforms. Rehinged sits at a different layer of the commercial stack.
AcuityMD, Definitive Healthcare and Trella Health can be valuable inputs or systems inside a mature commercial stack. Rehinged is designed to answer the GTM question and produce the work around it.
Most Market Drafts are live within 1–2 business days. We’ll tell you if one takes longer.
Once your Full Build is complete, we can scope additional commercial work against the market we’ve built together. See the finished work →
The test is cheaper than building the wrong commercial organization.
Send the founder directly or tell us who you want us to look at.
We test the market, buyer logic and GTM question against the available evidence.
No portfolio commitment. No requirement to buy a Full Build.
Give other portfolio companies a direct Rehinged referral path with attribution attached.
The partnership starts with evidence, not a partnership agreement.
Start with the company where getting the market wrong would be most expensive.
Prefer to send the founder directly? Get a referral link.
We’ll create a Rehinged referral link tied to your firm so the founder can complete the intake directly.
We’ll set up a Rehinged referral path tied to your firm so portfolio companies can submit their own Market Draft requests with your referral attached.
A portfolio company’s information stays with that company. Rehinged does not use one client’s confidential information to build another client’s market. We do not share a portfolio company’s Rehinged work or submitted information with a referring investor unless the company chooses to share it.
START WITH ONE COMPANY · MARKET DRAFT IS FREE · NO PORTFOLIO COMMITMENT